期刊
MOLECULAR AND CELLULAR ENDOCRINOLOGY
卷 335, 期 1, 页码 2-13出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2010.04.005
关键词
Glucocorticoid; Inflammation; 11 beta-Hydroxysteroid dehydrogenase
资金
- Medical Research Council
- Wellcome Trust
- MRC [G0800235] Funding Source: UKRI
- Medical Research Council [G0800235] Funding Source: researchfish
Since the discovery of glucocorticoids in the 1940s and the recognition of their anti-inflammatory effects, they have been amongst the most widely used and effective treatments to control inflammatory and autoimmune diseases. However, their clinical efficacy is compromised by the metabolic effects of long-term treatment, which include osteoporosis, hypertension, dyslipidaemia and insulin resistance/type 2 diabetes mellitus. In recent years, a great deal of effort has been invested in identifying compounds that separate the beneficial anti-inflammatory effects from the adverse metabolic effects of glucocorticoids, with limited effect. It is clear that for these efforts to be effective, a greater understanding is required of the mechanisms by which glucocorticoids exert their anti-inflammatory and immunosuppressive actions. Recent research is shedding new light on some of these mechanisms and has produced some surprising new findings. Some of these recent developments are reviewed here. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据